Drug intelligence / Profile preview

Algita D

Development stage
Unknown
Lead developer
Labaid Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Algita D is an oral nutritional supplement developed and marketed by Labaid Pharmaceuticals in Bangladesh. It is a combination product containing calcium carbonate (500 mg elemental calcium) derived from an algae source and vitamin D3 (200 IU cholecalciferol). The supplement is indicated for the treatment and prevention of bone-related conditions, including osteoporosis, osteomalacia, tetany, hypoparathyroidism, and osteogenesis disorders. Its mechanism of action involves providing essential calcium for bone mineralization and utilizing vitamin D3 to enhance intestinal calcium absorption and maintain systemic calcium homeostasis. The algae-derived calcium source is often highlighted for its potential bioavailability and natural origin compared to mineral-sourced alternatives.

Brand names
Algita D
Other names
Calcium & Vitamin D3
02

Targets

TRPV6 (Transient receptor potential cation channel subfamily V member 6)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Algita D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algita D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call